If Fed eases further, S&P 500 could pass 8,000 in 2026, says JPMorgan's Lakos
Youtube· 2025-12-16 21:12
Let's welcome in now JP Morgan's head of global market strategy Jabravco Leakos. It's good to have you. It's been a minute. It's good to have you back.>> Thank you for having us. >> Let's just play off of what we just got from from Bostic and he's he's not going to vote. Um so it's sort of moot unless he represents a more hawkish side of the Fed.You suggest as you're bullish for next year that if the Fed eases further on the back of improving inflation dynamics, S&P could go past 8,000 next year. That's pre ...
Picton Mahoney Asset Management Announces Distribution for PICTON Long Short Equity (130/30) Alternative Fund Exchange Traded Fund Units
Globenewswire· 2025-12-16 21:12
TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- (TSX: PFAE) Picton Mahoney Asset Management announced today that it has declared the December 2025 year-end cash distribution of $0.0887 per unit for the ETF units (“ETF Units”) of the PICTON Long Short Equity (130/30) Alternative Fund. Unitholders of record of the ETF Units, at the close of business on December 22, 2025, will receive a per-unit cash distribution payable on December 31, 2025. About Picton Mahoney Asset Management Picton Mahoney Asset Management spe ...
Alector Stock Down After Latozinemab Failure, Eyes On Phase 2 Catalyst (ALEC)
Seeking Alpha· 2025-12-16 21:10
Alector Inc. ( ALEC ) stock has had quite a volatile year. We saw great momentum from the company as it progressed with Latozinemab through the pipeline. However, in late October, we saw a less-than-positive data readout, which droppedI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me ...
Essential Properties Realty Trust, Inc. Announces New Chief Financial Officer
Businesswire· 2025-12-16 21:10
PRINCETON, N.J.--(BUSINESS WIRE)--Essential Properties Realty Trust, Inc. (NYSE: EPRT; the "Company†), today announced the appointment of Robert W. Salisbury, CFA as the Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2026. In connection with Mr. Salisbury's appointment, Mark E. Patten will resign from all his roles at the Company, effective as of December 31, 2025, to pursue a new professional opportunity. About Essential Properties Realty Trust, Inc. Essential P ...
Fed's Bostic: Concerned rate cuts could unanchor inflation expectations
Youtube· 2025-12-16 21:08
Hey, Scott. Yeah. Outgoing Atlanta Fed President Raphael Bostics uh not too concerned about the jobs numbers uh saying he expected them, but he was opposed to the last rate cut says the Fed's credibility is on the line with 5 years of above target inflation.He's concerned rate cuts could anchor inflation expectations uh could unanchor uh inflation expectations. The surveys that he does at the from the Atlanta Fed show firms will continue to increase prices into 2026. the Fed, he says, should keep policy res ...
Citi continues overseas retreat with sale of Banamex stake
American Banker· 2025-12-16 21:06
Citi has been shrinking its international consumer banking franchise for nearly five years as part of CEO Jane Fraser's plan to refashion the megabank into a smaller, simpler company. Processing ContentThe latest milestone in that process came Monday, when Citi announced the completion of the sale of a 25% stake in Grupo Financiero Banamex, its retail banking subsidiary in Mexico. Selling one-quarter of Banamex to Mexican businessman Fernando Chico Pardo is "a very significant part and step" in the bank's ...
Want $1 Million In Retirement? Invest $50,000 in These 2 Stocks and Wait a Decade
The Motley Fool· 2025-12-16 21:05
Plug Power and ChargePoint could be potential tenbaggers.Many Americans consider $1 million in savings to be a baseline for a comfortable retirement. Unfortunately, fewer than 5% of Americans have actually reached that milestone, according to a recent analysis by the Employee Benefits Research Institute of Federal Reserve data.If you have at least a decade until retirement, you should probably ramp up your investments. For example, a simple $100,000 investment in an S&P 500 index fund could still blossom to ...
BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globenewswire· 2025-12-16 21:05
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 5:15 p.m. PT. A live webcast of the presentation will be accessible on the “Events” page of the BBOT website at https://investors.bbot ...
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Businesswire· 2025-12-16 21:05
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx†or the "Company†), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2026 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time), during which GoodRx will discuss business updates. A live webcast will be available on the Company's Invest ...
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Globenewswire· 2025-12-16 21:05
Châtillon, France, December 16, 2025 DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years VITESSE met its primary endpoint: the lower bound of the 95% confidence interval (CI) of the difference between treatment arms was 24.5%, exceeding the prespecified threshold of 15% 46.6% of children treated with the VIASKIN® Peanut patch met response criteria at 12 months, compared to 14.8% of children in the placebo arm Sa ...